Menopause Completed Phase Trials for Atomoxetine (DB00289)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00611533Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal WomenTreatment